Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18799288 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: d-cycloserine
2 Enrolling by invitation Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
Conditions: Schizophrenia;   Bipolar Disorder
Interventions: Drug: D-cycloserine;   Drug: placebo

Indicates status has not been verified in more than two years